Blackstone Life Sciences Overview

  • Investor Type
  • PE/​Buyout
  • Status
  • Active
  • Investments
  • 114
  • Portfolio
  • 20
  • Exits
  • 61
Exits

Blackstone Life Sciences General Information

Description

Blackstone Life Sciences is a segment of the private equity firm, The Blackstone Group. The firm prefers to invest in companies operating in the life science, pharma, medical device research, biotechnology, and healthcare sectors. The firm is a result of The Blackstone Group's acquisition of Clarus Ventures in 2018.

Contact Information

Formerly Known As
Clarus Ventures, LLC, Clarus, Clarus-Ventures, Klarus Ventures, ClarusVentures, Clarus Venture, Clarus Ventures, Limited Liability Company, Clarus Ventures
Year Founded
2005
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
PE/Buyout
Other Investor Types
Venture Capital
Primary Office
  • 101 Main Street
  • Suite 1210
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Blackstone Life Sciences Investments & Acquisitions (114)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000 00000000000 19-Nov-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3
0000000 0000000000 30-Sep-2020 00000 00000 00000 Drug Delivery Clinical Trials - Phase 3 00000 0000000 00
0000000 0000000000 17-Aug-2020 0000000000 000 Buildings and Property 00000000 000000000 00.0
000000 28-Jul-2020 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 000 00000000 00
Annexon Biosciences 30-Jun-2020 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 1 000000 0000000000 00.0
You’re viewing 5 of 114 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Blackstone Life Sciences Exits (61)

Company Name Exit Date Exit Type Exit Size
000000 16-Oct-2020 000 00000
0000000 000000 25-Sep-2020 000 0000
0000000 0000000000 24-Jul-2020 000 00000
000000 00000000000 07-Nov-2019 000 0000
Essa Pharma 23-Aug-2019 Public Investment 2nd Offering 0000
You’re viewing 5 of 61 exits. Get the full list »

Blackstone Life Sciences Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Blackstone Life Sciences‘s full profile, request access.

Request a free trial

Blackstone Life Sciences Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Blackstone Life Sciences Team (34)

Name Title Deals Funds Boards Office
Kurt Wheeler Co-Founder & Managing Director 00 0 0 Cambridge, MA
Nicholas Simon Managing Director 0 0 0 Cambridge, MA
Robert Liptak Managing Director 0 0 Cambridge, MA
Kiran Reddy MD Venture Partner 0 0 Cambridge, MA
Scott Requadt JD Venture Partner 0 0 0 Cambridge, MA
You’re viewing 5 of 34 team members. Get the full list »